VERO® radiotherapy for low burden cancer: 789 patients with 957 lesions

Roberto Orecchia,A. Surgo,Matteo Muto,A. Ferrari,Gaia Piperno,M. Gerardi,S. Comi,C. Garibaldi,D. Ciardo,A. Bazani,Federica Golino,F. Pansini,C. Fodor,Paola Romanelli,D. Maestri,Valerio Scroffi,Stefano Mazza,B.A. Jereczek-Fossa

VERO® radiotherapy for low burden cancer: 789 patients with 957 lesions

2016

Roberto Orecchia
A. Surgo
Matteo Muto
A. Ferrari
Gaia Piperno
M. Gerardi
S. Comi
C. Garibaldi
D. Ciardo
A. Bazani
Federica Golino
F. Pansini
C. Fodor
Paola Romanelli
D. Maestri
Valerio Scroffi
Stefano Mazza
B.A. Jereczek-Fossa

Purpose The aim of this retrospective study is to evaluate patient profile, feasibility, and acute toxicity of RadioTherapy (RT) delivered by VERO® in the first 20 months of clinical activity.

Keywords:

Patient profile
Radiology
Gynecology
Cancer
Acute toxicity
Retrospective cohort study
Medicine
Radiation therapy
Surgery
Toxicity
Pelvis
Thorax
Lesion

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations